Gloria Melanie 4

What Happened Gloria Melanie, Chief Operating Officer of Immunovant (IMVT), sold a total of 2,036 shares on July 8, 2026 for aggregate proceeds of about $80,532. The sale consisted of 1,930 shares at a weighted-average price of $39.53 (proceeds $76,293) and 106 shares at a weighted-average price of $39.99 (proceeds $4,239). This was a sale (not a purchase) and was performed to cover tax withholding obligations related to RSU vesting, not an independent discretionary sale.

Key Details

• Transaction date: July 8, 2026 (Form 4 filed July 10, 2026—timely within the typical two-business-day window).
• Shares sold and prices:
  • 1,930 shares disposed at weighted-average $39.53 (range reported 38.91–39.89 per footnote).
  • 106 shares disposed at weighted-average $39.99 (range reported 39.92–40.03 per footnote).
• Total proceeds: approximately $80,532.
• Reason: Sell-to-cover tax withholding for RSUs granted April 1, 2025; 4,761 RSUs vested on July 1, 2026 (footnote states sale was mandatory to satisfy withholding and not discretionary).
• Disclosure note: Footnotes state the prices are weighted averages and that the Reporting Person will provide a breakdown of shares sold at each price upon request.
• Shares owned after the transaction: not specified in the provided excerpt of the filing—see the full Form 4 for post-transaction beneficial ownership.

Context: This was a routine sell-to-cover tied to vested RSUs (tax withholding), which is common and generally not interpreted as a statement about the insider’s view of the company.